[13]
Altay, O.; Mohammadi, E.; Lam, S.; Turkez, H.; Boren, J.; Nielsen, J.; Uhlen, M.; Mardinoglu, A. Current status of covid-19 therapies and drug repositioning applications. iscience, 2020, 23(7), 101303,
[31]
Chen, D.; Yang, H.; Cao, Y.; Cheng, W.; Duan, T.; Fan, C.; Fan, S.; Feng, L.; Gao, Y.; He, F.; He, J.; Hu, Y.; Jiang, Y.; Li, Y.; Li, J.; Li, X.; Li, X.; Lin, K.; Liu, C.; Liu, J.; Liu, X.; Pan, X.; Pang, Q.; Pu, M.; Qi, H.; Shi, C.; Sun, Y.; Sun, J.; Wang, X.; Wang, Y.; Wang, Z.; Wang, Z.; Wang, C.; Wu, S.; Xin, H.; Yan, J.; Zhao, Y.; Zheng, J.; Zhou, Y.; Zou, L.; Zeng, Y.; Zhang, Y.; Guan, X. Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection.
Int. J. Gynaecol. Obstet., 2020,
149(2), 130-136.
[
http://dx.doi.org/10.1002/ijgo.13146] [PMID:
32196655]
[47]
Jin, Y.H.; Cai, L.; Cheng, Z.S.; Cheng, H.; Deng, T.; Fan, Y.P.; Fang, C.; Huang, D.; Huang, L.Q.; Huang, Q.; Han, Y.; Hu, B.; Hu, F.; Li, B.H.; Li, Y.R.; Liang, K.; Lin, L.K.; Luo, L.S.; Ma, J.; Ma, L.L.; Peng, Z.Y.; Pan, Y.B.; Pan, Z.Y.; Ren, X.Q.; Sun, H.M.; Wang, Y.; Wang, Y.Y.; Weng, H.; Wei, C.J.; Wu, D.F.; Xia, J.; Xiong, Y.; Xu, H.B.; Yao, X.M.; Yuan, Y.F.; Ye, T.S.; Zhang, X.C.; Zhang, Y.W.; Zhang, Y.G.; Zhang, H.M.; Zhao, Y.; Zhao, M.J.; Zi, H.; Zeng, X.T.; Wang, Y.Y.; Wang, X.H.; Management, Z.H.W.U.N.C. for the Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM) A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).
Mil. Med. Res., 2020,
7(1), 4.
[
http://dx.doi.org/10.1186/s40779-020-0233-6] [PMID:
32029004]
[49]
Yıldız, P.A.; Dizbay, M. COVID-19’un Klinik Bulguları ve Tedavisi. GMJ, 2020, 31, 255-259.
[55]
Choy, K.T.; Wong, A.Y.L.; Kaewpreedee, P.; Sia, S.F.; Chen, D.D.; Hui, K.P.Y.; Chu, D.K.W.; Chan, M.C.W.; Cheung, P.P.H.; Huang, X.H.; Peiris, M.; Yen, H.L. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro; Antivir Res, 2020, p. 178.
[56]
Cao, B.; Wang, Y.; Wen, D.; Liu, W.; Wang, J.; Fan, G.; Ruan, L.; Song, B.; Cai, Y.; Wei, M.; Li, X.; Xia, J.; Chen, N.; Xiang, J.; Yu, T.; Bai, T.; Xie, X.; Zhang, L.; Li, C.; Yuan, Y.; Chen, H.; Li, H.; Huang, H.; Tu, S.; Gong, F.; Liu, Y.; Wei, Y.; Dong, C.; Zhou, F.; Gu, X.; Xu, J.; Liu, Z.; Zhang, Y.; Li, H.; Shang, L.; Wang, K.; Li, K.; Zhou, X.; Dong, X.; Qu, Z.; Lu, S.; Hu, X.; Ruan, S.; Luo, S.; Wu, J.; Peng, L.; Cheng, F.; Pan, L.; Zou, J.; Jia, C.; Wang, J.; Liu, X.; Wang, S.; Wu, X.; Ge, Q.; He, J.; Zhan, H.; Qiu, F.; Guo, L.; Huang, C.; Jaki, T.; Hayden, F.G.; Horby, P.W.; Zhang, D.; Wang, C. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
N. Engl. J. Med., 2020,
382(19), 1787-1799.
[
http://dx.doi.org/10.1056/NEJMoa2001282] [PMID:
32187464]
[64]
Li, H.; Liu, S. M.; Yu, X. H.; Tang, S. L.; Tang, C. K. .Coronavirus
disease 2019 (COVID-19): Current status and future perspectives.
Int J Antimicrob Ag, 2020, 55(5),
[73]
Grein, J.; Ohmagari, N.; Shin, D.; Diaz, G.; Asperges, E.; Castagna, A.; Feldt, T.; Green, G.; Green, M.L.; Lescure, F.X.; Nicastri, E.; Oda, R.; Yo, K.; Quiros-Roldan, E.; Studemeister, A.; Redinski, J.; Ahmed, S.; Bernett, J.; Chelliah, D.; Chen, D.; Chihara, S.; Cohen, S.H.; Cunningham, J.; D’Arminio Monforte, A.; Ismail, S.; Kato, H.; Lapadula, G.; L’Her, E.; Maeno, T.; Majumder, S.; Massari, M.; Mora-Rillo, M.; Mutoh, Y.; Nguyen, D.; Verweij, E.; Zoufaly, A.; Osinusi, A.O.; DeZure, A.; Zhao, Y.; Zhong, L.; Chokkalingam, A.; Elboudwarej, E.; Telep, L.; Timbs, L.; Henne, I.; Sellers, S.; Cao, H.; Tan, S.K.; Winterbourne, L.; Desai, P.; Mera, R.; Gaggar, A.; Myers, R.P.; Brainard, D.M.; Childs, R.; Flanigan, T. Compassionate Use of Remdesivir for Patients with Severe Covid-19.
N. Engl. J. Med., 2020,
382(24), 2327-2336.
[
http://dx.doi.org/10.1056/NEJMoa2007016] [PMID:
32275812]
[74]
Wang, Y.; Zhang, D.; Du, G.; Du, R.; Zhao, J.; Jin, Y.; Fu, S.; Gao, L.; Cheng, Z.; Lu, Q.; Hu, Y.; Luo, G.; Wang, K.; Lu, Y.; Li, H.; Wang, S.; Ruan, S.; Yang, C.; Mei, C.; Wang, Y.; Ding, D.; Wu, F.; Tang, X.; Ye, X.; Ye, Y.; Liu, B.; Yang, J.; Yin, W.; Wang, A.; Fan, G.; Zhou, F.; Liu, Z.; Gu, X.; Xu, J.; Shang, L.; Zhang, Y.; Cao, L.; Guo, T.; Wan, Y.; Qin, H.; Jiang, Y.; Jaki, T.; Hayden, F.G.; Horby, P.W.; Cao, B.; Wang, C. Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial.
Lancet, 2020,
395(10236), 1569-1578.
[
http://dx.doi.org/10.1016/S0140-6736(20)31022-9] [PMID:
32423584]
[76]
Chen, C.; Zhang, Y.; Huang, J.; Yin, P.; Cheng, Z.; Wu, J.; Chen, S.; Zhang, Y.; Chen, B.; Lu, M.; Luo, Y.; Ju, L.; Zhang, J.; Wang, X. Favipiravir versus arbidol for covid-19: A randomized clinical trial. Preprint from medRxiv,, 2020.
[77]
Cai, Q.; Yang, M.; Liu, D.; Chen, J.; Shu, D.; Xia, J.; Liao, X.; Gu, Y.; Cai, Q.; Yang, Y.; Shen, C.; Li, X.; Peng, L.; Huang, D.; Zhang, J.; Zhang, S.; Wang, F.; Liu, J.; Chen, L.; Chen, S.; Wang, Z.; Zhang, Z.; Cao, R.; Zhong, W.; Liu, Y.; Liu, L. Experimental
Treatment with Favipiravir for COVID-19: An Open-Label Control
Study. Engineering (Beijing),, 2020.
[83]
Paik, S.W. Side effects of peginterferon and ribavirin treatment for hepatitis C and their management. SILS 2009-The 5th Seoul International
Liver Symposium (Symposium III Current and future issues
in hepatitis C treatment), 2009, pp. 43-48.,
[84]
Li, Y.; Xie, Z.; Lin, W.; Cai, W.; Wen, C.; Guan, Y.; Mo, X.; Wang, J.; Wang, Y.; Peng, P.; Chen, X.; Hong, W.; Xiao, G.; Liu, J.; Zhang, L.; Hu, F.; Li, F.; Zhang, F.; Deng, X.; Li, L. Efficacy
and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with
230 Mini-Reviews in Medicinal Chemistry, 2022, Vol. 22, No. 2 Ünlü et al.
Mild/Moderate COVID-19: An Exploratory Randomized Controlled
Trial. Med (N Y), 2020;
[92]
Magagnoli, J.; Narendran, S.; Pereira, F.; Cummings, T.H.; Hardin, J.W.; Sutton, S.S.; Ambati, J. Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19; Med, N Y, 2020.
[111]
Yamasmith, E. Efficacy and safety of ivermectin against dengue infection: a phase III, randomized, double-blind, placebo-controlled trial.He 34th Annual Meeting the Royal College of Physicians of Thailand, Internal Medicine and One Health, Chonburi, Thailand 2018.
